Prazosin in hypertension with heart failure

Area of Science:

• Cardiology
• Pharmacology

Background:

• Hypertensive heart failure presents a complex clinical challenge, requiring management of both elevated blood pressure and impaired cardiac function.
• Diuretic agents are standard therapy for fluid management in heart failure, but their efficacy in addressing the hypertensive component can be limited.

Purpose of the Study:

• To evaluate the efficacy and safety of prazosin in combination with diuretic agents (furosemide and polythiazide) for treating patients with hypertensive heart failure.

Main Methods:

• A study involving 11 patients diagnosed with hypertensive heart failure.
• Patients received daily doses of prazosin ranging from 6 to 16 mg, alongside furosemide and polythiazide.
• Cardiac function indices, including ejection fraction and ejection time, were monitored.

Main Results:

• Significant reductions in both supine and standing blood pressures were observed, from an average of 180/108 mmHg and 171/106 mmHg to 130/84 mmHg and 135/86 mmHg, respectively.
• Average heart rate decreased in both supine and standing positions.
• Improvements in left ventricular function were indicated by changes in cardiac function indices.

Conclusions:

• Prazosin, when used concurrently with diuretic agents, demonstrates significant efficacy in managing hypertensive heart failure.
• This combination therapy effectively reduces blood pressure and heart rate while improving cardiac function.
• The treatment regimen showed a favorable side effect profile, suggesting its utility for simultaneous management of heart failure and hypertension.